112 related articles for article (PubMed ID: 2068121)
1. Factors affecting anti-estrogen binding site concentration in rat liver.
How BE; Hwang PL
Proc Soc Exp Biol Med; 1991 Jul; 197(3):279-84. PubMed ID: 2068121
[TBL] [Abstract][Full Text] [Related]
2. Estrogenic stimulation of the antiestrogen specific binding site in rat uterus and liver.
Winneker RC; Clark JH
Endocrinology; 1983 Jun; 112(6):1910-5. PubMed ID: 6682755
[TBL] [Abstract][Full Text] [Related]
3. Microsomal binding sites for antioestrogens in rat liver. Properties and detergent solubilization.
Watts CK; Sutherland RL
Biochem J; 1986 Jun; 236(3):903-11. PubMed ID: 3790095
[TBL] [Abstract][Full Text] [Related]
4. Resistance to tamoxifen with persisting sensitivity to estrogen: possible mediation by excessive antiestrogen binding site activity.
Pavlik EJ; Nelson K; Srinivasan S; Powell DE; Kenady DE; DePriest PD; Gallion HH; van Nagell JR
Cancer Res; 1992 Aug; 52(15):4106-12. PubMed ID: 1638522
[TBL] [Abstract][Full Text] [Related]
5. Antiestrogen binding sites in microsomal fractions of malignant and nonmalignant human breast tissues.
Mehta RR; DasGupta TK
Breast Cancer Res Treat; 1987; 9(1):61-7. PubMed ID: 3593991
[TBL] [Abstract][Full Text] [Related]
6. Studies on the ligand specificity and potential identity of microsomal antiestrogen-binding sites.
Watts CK; Sutherland RL
Mol Pharmacol; 1987 May; 31(5):541-51. PubMed ID: 3553893
[TBL] [Abstract][Full Text] [Related]
7. High affinity specific antiestrogen binding sites are concentrated in rough microsomal membranes of rat liver.
Watts CK; Sutherland RL
Biochem Biophys Res Commun; 1984 Apr; 120(1):109-15. PubMed ID: 6712683
[TBL] [Abstract][Full Text] [Related]
8. Possible mechanisms for the agonist actions of tamoxifen and the antagonist actions of MER-25 (ethamoxytriphetol) in the mouse uterus.
Lyman SD; Jordan VC
Biochem Pharmacol; 1985 Aug; 34(15):2795-806. PubMed ID: 4015716
[TBL] [Abstract][Full Text] [Related]
9. Estrogen and antiestrogen binding sites in desmoid tumors.
Lim CL; Walker MJ; Mehta RR; Das Gupta TK
Eur J Cancer Clin Oncol; 1986 May; 22(5):583-7. PubMed ID: 3770030
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, binding and structure-affinity studies of new ligands for the microsomal anti-estrogen binding site (AEBS).
Poirot M; De Medina P; Delarue F; Perie JJ; Klaebe A; Faye JC
Bioorg Med Chem; 2000 Aug; 8(8):2007-16. PubMed ID: 11003145
[TBL] [Abstract][Full Text] [Related]
11. Antiestrogen binding sites in brain and pituitary of ovariectomized rats.
Gray JM; Ziemian L
Brain Res; 1992 Apr; 578(1-2):55-60. PubMed ID: 1511289
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of the microsomal tamoxifen binding site.
Kedjouar B; de Médina P; Oulad-Abdelghani M; Payré B; Silvente-Poirot S; Favre G; Faye JC; Poirot M
J Biol Chem; 2004 Aug; 279(32):34048-61. PubMed ID: 15175332
[TBL] [Abstract][Full Text] [Related]
13. Subcellular and extracellular localization of specific binding sites for triphenylethylene antiestrogens in human breast cancer.
Gulino A; Vacca A; Modesti A; Screpanti I; Farina A; Frati L
Biochem Pharmacol; 1986 Nov; 35(21):3863-70. PubMed ID: 3778510
[TBL] [Abstract][Full Text] [Related]
14. Modifications of benzylphenoxy ethanamine antiestrogen molecules: influence affinity for antiestrogen binding site (AEBS) and cell cytotoxicity.
Delarue F; Kedjouar B; Mésange F; Bayard F; Faye JC; Poirot M
Biochem Pharmacol; 1999 Mar; 57(6):657-61. PubMed ID: 10037451
[TBL] [Abstract][Full Text] [Related]
15. Comparative affinity of steroidal and non-steroidal antioestrogens, cholesterol derivatives and compounds with a dialkylamino side chain for the rat liver antioestrogen binding site.
van den Koedijk CD; Vis van Heemst C; Elsendoorn GM; Thijssen JH; Blankenstein MA
Biochem Pharmacol; 1992 Jun; 43(12):2511-8. PubMed ID: 1632810
[TBL] [Abstract][Full Text] [Related]
16. Antiestrogen binding within different pituitary cell populations. Comparison with androgen and estrogen receptors.
Thieulant ML; Adelaide J; Duval J
J Steroid Biochem; 1986 Jan; 24(1):395-9. PubMed ID: 3702423
[TBL] [Abstract][Full Text] [Related]
17. Identification and pharmacological characterization of cholesterol-5,6-epoxide hydrolase as a target for tamoxifen and AEBS ligands.
de Medina P; Paillasse MR; Segala G; Poirot M; Silvente-Poirot S
Proc Natl Acad Sci U S A; 2010 Jul; 107(30):13520-5. PubMed ID: 20615952
[TBL] [Abstract][Full Text] [Related]
18. Microsomal antiestrogen-binding site ligands induce growth control and differentiation of human breast cancer cells through the modulation of cholesterol metabolism.
Payré B; de Medina P; Boubekeur N; Mhamdi L; Bertrand-Michel J; Tercé F; Fourquaux I; Goudounèche D; Record M; Poirot M; Silvente-Poirot S
Mol Cancer Ther; 2008 Dec; 7(12):3707-18. PubMed ID: 19074846
[TBL] [Abstract][Full Text] [Related]
19. Structural similitudes between cytotoxic antiestrogen-binding site (AEBS) ligands and cytotoxic sigma receptor ligands. Evidence for a relationship between cytotoxicity and affinity for AEBS or sigma-2 receptor but not for sigma-1 receptor.
Kedjouar B; Daunes S; Vilner BJ; Bowen WD; Klaebe A; Faye JC; Poirot M
Biochem Pharmacol; 1999 Dec; 58(12):1927-39. PubMed ID: 10591147
[TBL] [Abstract][Full Text] [Related]
20. Hepatic estrogen responsiveness. Possible mechanisms for sexual dimorphism.
Thompson C; Lucier GW
Mol Pharmacol; 1983 Jul; 24(1):69-76. PubMed ID: 6865928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]